SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-072652
Filing Date
2023-12-22
Accepted
2023-12-22 16:24:29
Documents
6
Period of Report
2023-12-23

Document Format Files

Seq Description Document Type Size
1 6-K asln_6-k_-_12222023.htm 6-K 34793
2 EX-99.1 asln-ex99_1.htm EX-99.1 34320
3 EX-99.2 asln-ex99_2.htm EX-99.2 245519
4 GRAPHIC img183322545_0.jpg GRAPHIC 642868
5 GRAPHIC img183322545_1.jpg GRAPHIC 274701
6 GRAPHIC img184246066_0.jpg GRAPHIC 31676
  Complete submission text file 0000950170-23-072652.txt   1623218
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 231510134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)